Thor Lindvaag, appointed to oversee the new office in Trondheim, Norway, said: "The entire European market is buying American nutraceutical products at an ever increasing rate. Desert Health plans to be a major player in this lucrative area."
The company claims to have shipped nearly 1 million capsules and tablets to the market since the beginning of the year.
Desert Health began trading on the Frankfurt Stock Exchange earlier this month to raise its profile in Europe and increase its shareholder base to support growth. It already has an office in Beijing serving the Asian market and has plans to expand to Ecuador.
A European base will allow the firm to develop new customers in the region and should lead to increased awareness of the European consumer's requirements in supplements, said Johnny Shannon, chairman and CEO of Desert Health.
The company has also signed a 10-year licensing agreement with Royal Products Scandinavia, a direct sales marketing company set up in Norway last year. Desert Health will make royalties on sales of RPS products to its customers.
The Scottsdale, Arizona-based company, which has branded over 200 products, reported a loss of $2.2 million for 2002 on sales of only $133,703.